The UK health secretary announces that more black men will be invited to take part in a prostate cancer screening trial. The expansion is linked to Transform, a study designed to test better ways of identifying prostate cancer that requires treatment. The plan follows a decision by the UK National Screening Committee (UKNSC), which recommends against population-wide prostate cancer screening. Instead, screening is focused on a smaller group considered at higher risk. Reporting indicates that only a few thousand men will be invited, including those with a specific gene mutation, and that eligibility is being broadened to include more black men within that risk group. The move is presented as part of efforts to improve the accuracy of screening approaches, as experts say that blood tests alone are not reliable enough for most men. Outcomes from the trial are expected to inform whether screening methods could be expanded to a wider group in the future if they prove more accurate at detecting clinically significant cancers.